Annotation Detail for VAT1L
Basic Information
Top
| Gene Symbol: | VAT1L ( KIAA1576 ) |
|---|
| Gene Full Name: | vesicle amine transport protein 1 homolog (T. californica)-like |
|---|
| Band: | 16q23.1 |
|---|
| Quick Links | Entrez ID:57687; OMIM: NA; Uniprot ID:VAT1L_HUMAN; ENSEMBL ID: ENSG00000171724; HGNC ID: 29315 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Pathway ID | Pathway Name |
|---|
| P00029 | Huntington disease |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D014635 |
Valproic Acid |
Valproic Acid results in increased expression of VAT1L mRNA | increases expression | 19101580
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.57 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.56 | 19490988 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
6.65 | 17688650 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
4.03 | 17497229 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 18558336 18775368 15238991 17507914 18396377 19232924 18985861 16609825 20603192 18177632 19460635 17157402 18940202 17688650 18316065 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.30 | 17594078 20046352 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.72 | 8888407 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.85 | 20734317 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.91 | 17688650 16575769 8888407 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.28 | 19641884 1733752 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.75 | 1851702 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
5.06 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
5.33 | 3922381 16628512 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.16 | 20417680 18234410 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
4.11 | 6426943 7562514 6254150 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
5.20 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
5.15 | 3659116 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.92 | 14986274 19224547 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
6.30 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.92 | 18558336 8888407 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.96 | 17688650 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.21 | 17596541 16294345 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
5.68 | 17228818 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.57 | 18803445 18765137 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.66 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.42 | 17596541 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.45 | 16359493 8888407 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.92 | 20603192 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.96 | 12752131 11422049 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.87 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.11 | 19110320 15737665 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
3.08 | 17978042 14763951 11738929 1511512 15475178 11044598 3137016 16876388 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.21 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.96 | 12833885 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
6.65 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.61 | 3119515 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.55 | 8888407 |
PharmGKB Accession:PA128394700
| Releated disease ID |
Related disease Name |
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Related Diseases/Disorders